[ET Net News Agency, 7 March 2025] BOCI raised the target price for JD Health (06618) to
HKD45 from HKD30 and maintained the "buy" rating.
The research house said it expects the company will accelerate their proactive
investments in multiple areas including users, products, services, subsidies, offline
infrastructures, omni-channel initiatives and AI in 2025 in a disciplined manner. (rc)